Stories & Ideas

Featured blog

Behind the Breakthrough: Q&A with Meena Mallipeddi, AmplifyMD

Meena Mallipeddi is one of the visionary leaders behind AmplifyMD working to e...

Featured blog

The Four Ds of Digital Health

In the dynamic landscape of healthcare's digital transformation, where data ac...

Stories & Ideas

By: F-Prime Capital

Behind the Breakthrough: Q&A with Meena Mallipeddi, AmplifyMD

By: Carl Byers

The Four Ds of Digital Health

By: F-Prime Capital

Behind the Breakthrough: Q&A with Peptone, Kamil Tamiola

Structure Therapeutics

Biologics and peptides have revolutionized healthcare setting the stage for a ne...

By: F-Prime Capital

Behind the Breakthrough: Q&A with Lyn Baranowski, Avalyn Pharma

By: F-Prime Capital

Behind the Breakthrough: Q&A with Stephen Smith, NOCD

By: F-Prime Capital

F-Prime’s Summer Internship Program: Meet our 2023 interns and fellows

By: F-Prime Capital

Behind the Breakthrough: Q&A with Emanuele Ostuni, ARTBIO

Beam Therapeutics

The team developed a DNA base editing technology that enabled more precise edits...

By: Alex Pasteur, Ph.D., Martin Taylor, Ph.D.

ARTBIO: Redefining cancer care through an entirely new class of alpha radioligan...

By: Carl Byers

Why We Invested in Carrot Fertility: A global leader in fertility healthcare and...

CHARM Therapeutics

Predicting the structure and nature of protein-ligand interactions could enable ...

Denali Therapeutics

That needed to change. Through our affiliate FBRI, F-Prime has had a long-standi...

Equip

In 2019, Kristina Saffran and Dr. Erin Parks came to us with a slide deck and a ...

Prime Medicine

Using “search and replace” to address the fundamental causes of genetic disease.

Peptone

Many human proteins are intrinsically disordered and play a critical role in key...

Orchard Therapeutics

But he only had a few pieces in hand. He and his co-founders had some of the mos...

Atalanta

Achieving broad distribution of RNAi therapeutics throughout the CNS has been a ...

AviadoBio

Neurological disease remains the largest cause of disability and second leading ...

K36 Therapeutics

F-Prime has long been interested in precision medicine approaches that tackle th...

Ultragenyx

When he approached us, he was looking for an investor who would understand rare ...

Project Beacon

Boston’s life science community needed efficient, affordable, accessible and equ...

News

PR Newswire

Zealand Pharma Partners with Benchling to Advance R&D of Engineered Peptide Medicines

Endpoints News

Exclusive: In $1B+ bet on AI, biopharma heavyweights back new startup to upend drug R&D

PR Newswire

Zus Health Joins athenahealth's Marketplace Program to Bring Real-time Clinical Data to the Point of Care

PR Newswire

Panasonic and Shinobi Therapeutics Partner to Develop Efficient and Cost-Effective iPS Cell Therapy Manufacturing Technology

Fierce Biotech

With $290M in hand, newly emerged biotech Metsera thinks customizable combos are the future of obesity treatments

GlobeNewswire

Pulmocide Announces Successful Results from the OPERA-S Study: a Phase 2 Safety Study with Inhaled Opelconazole